IN2014DN06603A - - Google Patents

Info

Publication number
IN2014DN06603A
IN2014DN06603A IN6603DEN2014A IN2014DN06603A IN 2014DN06603 A IN2014DN06603 A IN 2014DN06603A IN 6603DEN2014 A IN6603DEN2014 A IN 6603DEN2014A IN 2014DN06603 A IN2014DN06603 A IN 2014DN06603A
Authority
IN
India
Prior art keywords
cells
brown adipose
artery derived
population
subject
Prior art date
Application number
Other languages
English (en)
Inventor
Agnieszka Seyda
David C Colter
Charito S Buensuceso
Christian C Kazanecki
Sridevi Dhanaraj
Original Assignee
Depuy Synthes Products Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Depuy Synthes Products Llc filed Critical Depuy Synthes Products Llc
Publication of IN2014DN06603A publication Critical patent/IN2014DN06603A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0653—Adipocytes; Adipose tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/35—Fat tissue; Adipocytes; Stromal cells; Connective tissues
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Cell Biology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • Microbiology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IN6603DEN2014 2012-02-15 2013-02-14 IN2014DN06603A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261599080P 2012-02-15 2012-02-15
PCT/US2013/026170 WO2013123214A1 (en) 2012-02-15 2013-02-14 Methods and composition related to brown adipose-like cells

Publications (1)

Publication Number Publication Date
IN2014DN06603A true IN2014DN06603A (pt) 2015-05-22

Family

ID=47757703

Family Applications (1)

Application Number Title Priority Date Filing Date
IN6603DEN2014 IN2014DN06603A (pt) 2012-02-15 2013-02-14

Country Status (16)

Country Link
US (1) US20130209418A1 (pt)
EP (1) EP2814949A1 (pt)
JP (1) JP2015508654A (pt)
KR (1) KR20140133574A (pt)
CN (1) CN104114693A (pt)
AU (1) AU2013221474A1 (pt)
BR (1) BR112014020229A8 (pt)
CA (1) CA2864103A1 (pt)
HK (1) HK1205185A1 (pt)
IN (1) IN2014DN06603A (pt)
MX (1) MX2014009837A (pt)
PH (1) PH12014501796A1 (pt)
RU (1) RU2014137102A (pt)
SG (1) SG11201404763XA (pt)
WO (1) WO2013123214A1 (pt)
ZA (1) ZA201406726B (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2013299377A1 (en) * 2012-08-10 2015-02-26 The Trustees Of Columbia University In The City Of New York Injectable brown adipose microtissues for treatment and prevention of obesity and diabetes
EP2986714B1 (en) * 2013-04-19 2021-01-06 Biorestorative Therapies, Inc. Human brown adipose derived stem cells and uses
US10092738B2 (en) * 2014-12-29 2018-10-09 Ethicon Llc Methods and devices for inhibiting nerves when activating brown adipose tissue
WO2017009263A1 (en) * 2015-07-10 2017-01-19 Etablissement Francais Du Sang Method for obtaining human brown/beige adipocytes
CN115433707A (zh) * 2015-12-07 2022-12-06 再生疗法有限公司 用于重新衍生不同的多能干细胞衍生的褐色脂肪细胞的方法
US20210077536A1 (en) 2019-04-29 2021-03-18 Biorestorative Therapies, Inc. Non-naturally occuring three-dimensional (3d) brown adipose-derived stem cell aggregates, and methods of generating and using the same
CN110484566B (zh) * 2019-08-29 2021-06-29 中国人民解放军第四军医大学 一种类棕色脂肪外泌体及其工程化生产方法和应用
WO2021106698A1 (ja) * 2019-11-25 2021-06-03 株式会社片岡製作所 培地用組成物
CN113493764B (zh) * 2021-07-27 2023-01-24 新乡医学院 一种体外诱导小鼠耳朵间充质干细胞分化为脂肪细胞的方法
CN114225006B (zh) * 2021-12-22 2023-10-13 南京市妇幼保健院 一种棕色脂肪细胞分泌肽在低体温疾病防治中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100150885A1 (en) * 2005-06-01 2010-06-17 Joslin Diabetes Center, Inc. Methods and compositions for inducing brown adipogenesis
JP2011523357A (ja) * 2008-05-06 2011-08-11 ジョスリン ダイアビーティス センター インコーポレイテッド 褐色脂肪細胞分化を誘導するための方法および組成物
EP2296478B1 (en) * 2008-05-27 2017-03-22 Olivier D. Boss Brown adipocyte progenitors in human skeletal muscle
US8323972B2 (en) * 2009-09-30 2012-12-04 Advanced Technologies And Regenerative Medicine, Llc Mammary artery derived cells and methods of use in tissue repair and regeneration

Also Published As

Publication number Publication date
SG11201404763XA (en) 2014-10-30
EP2814949A1 (en) 2014-12-24
PH12014501796A1 (en) 2014-11-24
US20130209418A1 (en) 2013-08-15
CN104114693A (zh) 2014-10-22
ZA201406726B (en) 2016-05-25
CA2864103A1 (en) 2013-08-22
KR20140133574A (ko) 2014-11-19
RU2014137102A (ru) 2016-04-10
MX2014009837A (es) 2014-09-16
BR112014020229A8 (pt) 2017-07-11
BR112014020229A2 (pt) 2017-06-20
AU2013221474A1 (en) 2014-09-25
HK1205185A1 (en) 2015-12-11
WO2013123214A1 (en) 2013-08-22
JP2015508654A (ja) 2015-03-23

Similar Documents

Publication Publication Date Title
IN2014DN06603A (pt)
Prunet-Marcassus et al. From heterogeneity to plasticity in adipose tissues: site-specific differences
NZ599830A (en) Novel kinase modulators
TR201903889T4 (tr) Korneal endotelyal hücreler üreten yönlendirilmiş diferansiyasyona yönelik yöntem.
MX355077B (es) Diferenciacion de celulas madre embrionarias humanas.
EP2555627A4 (en) METHOD FOR TREATING CARCINOMA
PH12014501429A1 (en) Differentiation of human embryonic stem cells into single hormonal insulin positive cells
NZ608734A (en) Bone marrow derived cd271 precursor cells for cardiac repair
MY160349A (en) Pyridone and aza-pyridone compounds and methods of use
AR093217A1 (es) Anticuerpos antagonistas mejorados contra factor-8 de crecimiento y diferenciacion y usos de los mismos
EP3943092A3 (en) Compositions for use in inducing differentiation of human brown adipocyte progenitors
WO2012000103A8 (en) Methods of targeting pten mutant diseases and compositions therefor
MX2013002405A (es) Diferenciacion de celulas madre embrionarias humanas.
WO2013124815A3 (en) Mesenchymal stem cells for in vitro modeling and cell-based therapy of human diseases and banks thereof
MX2019007057A (es) Composiciones de adenovirus.
WO2010104796A3 (en) Methods of modulating smooth muscle cell proliferation and differentiation
Zhang et al. Effects of Rehmannia glutinosa oligosaccharide on human adipose-derived mesenchymal stem cells in vitro
MY164969A (en) Bioactive compositions comprising ficus serum fraction and methods to reduce the appearance of skin hyperpigmentation
SG195127A1 (en) Methods of treating or preventing neurological diseases
Chen et al. Regulation of heme oxygenase 1 expression by miR-27b with stem cell therapy for liver regeneration in rats
Meregalli et al. Mesenchymal stem cells as muscle reservoir
MX2015007845A (es) Metodo para tratamiento de enfermedades.
WO2014072720A3 (en) Cell differentiation
WO2014005153A3 (en) Methods for treating mds1-evi1 mediated cancer
MX2014000186A (es) Un anticuerpoque induce tolerancia de celula t especifica de antigeno y uso del mismo.